94 related articles for article (PubMed ID: 26913392)
1. [Overexpression of SHP-1 Enhances the Sensitivity of K562 Cells to Imatinib].
Li YH; Liu XD; Guo XF; Liu X; Luo JM; Li ZS; Zhang YX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):46-51. PubMed ID: 26913392
[TBL] [Abstract][Full Text] [Related]
2. [SHP-1 gene in the disease progression of chronic myeloid leukemia].
Li Y; Wang X; Yang L; Pan Y; Shang Y; Luo J
Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1074-8. PubMed ID: 25543700
[TBL] [Abstract][Full Text] [Related]
3. [Suppression of NAMPT expression enhances the sensitivity of K562 cells to imatinib and its relative mechanism].
Lin PP; Bai XJ; Yue ZX; Yan SF; Li ZW; Gao C; Mei YY; Wang KL; Li WJ; Ding W; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):235-41. PubMed ID: 22541073
[TBL] [Abstract][Full Text] [Related]
4. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
5. Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway.
Liu Y; Song B; Wei Y; Chen F; Chi Y; Fan H; Liu N; Li Z; Han Z; Ma F
Cytotherapy; 2018 Feb; 20(2):181-188. PubMed ID: 29269240
[TBL] [Abstract][Full Text] [Related]
6. [Effect of phenylhexyl isothiocyanate on drug-resistance to imatinib in K562/G01 cell line].
Wu RJ; Huang YQ; Ma XD
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):149-52. PubMed ID: 23611223
[TBL] [Abstract][Full Text] [Related]
7. [Effect of Homoharringtonine Combined with Imatinib on the K562/G01 Cells and Its Mechanism].
Wu JJ; Ding YH; Deng ZK; Shi YY; Lu XY; Li YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):80-84. PubMed ID: 28245379
[TBL] [Abstract][Full Text] [Related]
8. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
Farhadi E; Zaker F; Safa M; Rezvani MR
Tumour Biol; 2016 Oct; 37(10):14117-14128. PubMed ID: 27517565
[TBL] [Abstract][Full Text] [Related]
9. [Effects of HO-1 gene expression on proliferation of imatinib resistant CML cells].
Wang JS; Chai BS; Fang Q; He YY; Chen C; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2011 Jun; 32(6):388-91. PubMed ID: 21781496
[TBL] [Abstract][Full Text] [Related]
10. [Effect of A Novel Emodin Derivative on Chronic Myelogenous Leukemia K562 Cells and Imatinib-resistant K562/G01 Cells].
Li BJ; Liu TB; Wang WF; Lin MH; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):1-7. PubMed ID: 26913384
[TBL] [Abstract][Full Text] [Related]
11. [Effect of a methylation inhibitor 5-aza-2'-deoxycytidine on SHP-1 gene expression, proliferation and apoptosis in K562 cells].
Luo JM; Li Y; Yang L; Liu XJ; Wen SP; Wang FX; Zhang JY; Zhang XJ; Dong ZR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):309-14. PubMed ID: 19379557
[TBL] [Abstract][Full Text] [Related]
12. [Acadesine Inhibits the Proliferation of K562 Cells and Enhances their Sensitivity to Imatinib].
Wu JJ; Wei B; Ding YH; Deng ZK; Shi YY; Li YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):36-40. PubMed ID: 26913390
[TBL] [Abstract][Full Text] [Related]
13. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro].
Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538
[TBL] [Abstract][Full Text] [Related]
14. Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1.
Wang W; Zhang J; Li Y; Yang X; He Y; Li T; Ren F; Zhang J; Lin R
Cancer Lett; 2015 Jan; 356(2 Pt B):791-9. PubMed ID: 25449787
[TBL] [Abstract][Full Text] [Related]
15. BM microenvironmental protection of CML cells from imatinib through Stat5/NF-κB signaling and reversal by Wogonin.
Xu X; Zhang X; Liu Y; Yang L; Huang S; Lu L; Wang S; Guo Q; Zhao L
Oncotarget; 2016 Apr; 7(17):24436-54. PubMed ID: 27027438
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells.
Lin TY; Chen KC; Liu HJ; Liu AJ; Wang KL; Shih CM
PLoS One; 2016; 11(5):e0156260. PubMed ID: 27228340
[TBL] [Abstract][Full Text] [Related]
17. EphB4-VAV1 signaling pathway is associated with imatinib resistance in chronic myeloid leukemia cells.
Zhang JF; Xu N; Du QF; Li R; Liu XL
Blood Cells Mol Dis; 2016 Jul; 59():58-62. PubMed ID: 27282569
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
[TBL] [Abstract][Full Text] [Related]
19. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Carter BZ; Wang X; Shi X; Liu J
J Hematol Oncol; 2016 Nov; 9(1):129. PubMed ID: 27884201
[TBL] [Abstract][Full Text] [Related]
20. [Effect of arsenic trioxide and 5-aza-2'-deoxycytidine on SHP-1, JAK3, TYK2 gene expression in K562 cells].
Zhang XK; Luo JM; Sun J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):323-8. PubMed ID: 24762999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
